Hordenine - Unapproved Dietary Ingredient

C. Muralikrishna Goud, G. N. Pramodini, Raja Rajeshwari Kamisetti
{"title":"Hordenine - Unapproved Dietary Ingredient","authors":"C. Muralikrishna Goud, G. N. Pramodini, Raja Rajeshwari Kamisetti","doi":"10.52711/2231-5659.2023.00038","DOIUrl":null,"url":null,"abstract":"The present work focuses on providing awareness to the users of dietary supplement containing hordenine an unapproved dietary ingredient causing severe side effects. Hordenine is a new dietary ingredient that hasn’t been submitted to FDA to establish its safety. Hordinine is an ingredient without GRAS status. The U.S. Food and Drug Administration (FDA) recently determined hordenine to be a “new dietary ingredient (NDI) for which an NDI notification is required and has not yet been submitted” and not an approved dietary ingredient under the Dietary Supplement Health and Education Act of 1994 (DSHEA). Therefore, any product containing hordenine is considered “adulterated”. Rapid heart rates and high blood pressure are the side effects of hordenine that are more likely to occur in sensitive sub-populations of people such as pregnant women and consumers with cardiovascular disease. Usage of hordenine should be avoided during surgeries because of its side effects i.e rapid heart rates and high blood pressure. Dietary supplement products containing hordinine are not safe for weight loss and improving athletic performances and should be avoided for consuming.","PeriodicalId":8545,"journal":{"name":"Asian Journal of Research in Pharmaceutical Science","volume":"24 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Research in Pharmaceutical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52711/2231-5659.2023.00038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The present work focuses on providing awareness to the users of dietary supplement containing hordenine an unapproved dietary ingredient causing severe side effects. Hordenine is a new dietary ingredient that hasn’t been submitted to FDA to establish its safety. Hordinine is an ingredient without GRAS status. The U.S. Food and Drug Administration (FDA) recently determined hordenine to be a “new dietary ingredient (NDI) for which an NDI notification is required and has not yet been submitted” and not an approved dietary ingredient under the Dietary Supplement Health and Education Act of 1994 (DSHEA). Therefore, any product containing hordenine is considered “adulterated”. Rapid heart rates and high blood pressure are the side effects of hordenine that are more likely to occur in sensitive sub-populations of people such as pregnant women and consumers with cardiovascular disease. Usage of hordenine should be avoided during surgeries because of its side effects i.e rapid heart rates and high blood pressure. Dietary supplement products containing hordinine are not safe for weight loss and improving athletic performances and should be avoided for consuming.
Hordenine -未经批准的膳食成分
目前的工作重点是向含有hordenine的膳食补充剂的使用者提供意识,这是一种未经批准的膳食成分,会造成严重的副作用。Hordenine是一种新的膳食成分,尚未提交给FDA以确定其安全性。山葵碱是一种没有GRAS的成分。美国食品和药物管理局(FDA)最近确定,hordenine是一种“新的膳食成分(NDI),需要NDI通知,但尚未提交”,而不是1994年膳食补充剂健康和教育法(DSHEA)批准的膳食成分。因此,任何含有栀子碱的产品都被认为是“掺假”的。加速心率和高血压是hordenine的副作用,更容易发生在敏感人群中,如孕妇和患有心血管疾病的消费者。手术期间应避免使用hordenine,因为它的副作用是心率加快和高血压。含有蜂鸟碱的膳食补充剂对减肥和提高运动成绩是不安全的,应该避免食用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信